Homviotensin

Homviotensin is a homeopathic combination drug developed and marketed by Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG. It is indicated for the treatment of blood pressure disorders, specifically mild hypertension and fluctuating blood pressure. The preparation is a multi-ingredient formulation containing four plant-derived active ingredients: *Cactus* (D1), *Viscum album* (mistletoe mother tincture), *Rauwolfia* (D3), and *Crataegus* (hawthorn mother tincture). As a homeopathic product, it is purported to regulate and stabilize blood pressure values naturally while alleviating associated symptoms such as dizziness, headaches, and circulatory problems. It has been evaluated in Phase 2 clinical trials comparing its efficacy and sedative effects (measured via EEG theta power) to conventional treatments like metoprolol.

Brand names

Homviotensin